Article

SARS-CoV-2 variants of concern exhibit reduced sensitivity to live-virus neutralization in sera from CoronaVac vaccinees and naturally infected COVID-19 patients

2021-07-14

Abstract excerpt

Recent surges in SARS-CoV-2 variants of concern (VOCs) call for the need to evaluate levels of vaccine-and infection-induced SARS-CoV-2 neutralizing antibodies (NAbs). CoronaVac (Sinovac Biotech, Beijing, China) is currently being used for mass vaccination in Thailand as well as other low-income countries. Three VOCs currently circulating within Thailand include the B.1.1.7 (Alpha), B.1.351 (Beta), and B.1.617.2 (...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: d76dfd69-28c5-5d75-bd91-08bbe10cd02e
DOI: 10.1101/2021.07.10.21260232

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 variants of concern exhibit reduced sensitivity to live-virus neutralization in sera from CoronaVac vaccinees and naturally infected COVID-19 patientsDOI 10.1101/2021.07.10.21260232Read

Emerging SARS-CoV-2 variants of concern evade humoral immune responses from infection and vaccinationSemantic proximity Read

Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or Vaccination.Semantic proximity Read

Neutralization of SARS-CoV-2 variants B.1.617.1 and B.1.525 by BNT162b2-elicited seraSemantic proximity Read

Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccinesSemantic proximity Read

SARS-CoV-2 serotyping based on spike antigenicity and its implications for host immune evasionSemantic proximity Read

Reduced neutralization of SARS-CoV-2 B.1.617 variant by inactivated and RBD-subunit vaccineSemantic proximity Read

SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera.Semantic proximity Read

Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity.Semantic proximity Read

Reduced neutralization of B.1.351 variant SARS-CoV-2 by convalescent sera of COVID-19 patientsSemantic proximity Read

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines.Semantic proximity Read

Evasion of Vaccine-Induced Humoral Immunity by Emerging Sub-Variants of SARS-CoV-2Semantic proximity Read

Vaccine-induced and hybrid immunity against SARS-CoV-2 variants of concern in two cohorts in Queensland, Australia (2021-2022)Semantic proximity Read